JP2005515200A - 睡眠異常症（ｓｌｅｅｐｄｉｓｏｒｄｅｒ）等の治療、目覚め時の爽快感の付与を目的とした一化合物の使用及び前記化合物を用いた足元のふらつき（ｇｒｏｇｇｉｎｅｓｓ）の治療法 - Google Patents

睡眠異常症（ｓｌｅｅｐｄｉｓｏｒｄｅｒ）等の治療、目覚め時の爽快感の付与を目的とした一化合物の使用及び前記化合物を用いた足元のふらつき（ｇｒｏｇｇｉｎｅｓｓ）の治療法 Download PDF

Info

Publication number
JP2005515200A
JP2005515200A JP2003548835A JP2003548835A JP2005515200A JP 2005515200 A JP2005515200 A JP 2005515200A JP 2003548835 A JP2003548835 A JP 2003548835A JP 2003548835 A JP2003548835 A JP 2003548835A JP 2005515200 A JP2005515200 A JP 2005515200A
Authority
JP
Japan
Prior art keywords
sleep
triprolidine
active ingredient
hydrate
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003548835A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515200A5 (zh
Inventor
スンデルラージ、パラニスウァマイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JP2005515200A publication Critical patent/JP2005515200A/ja
Publication of JP2005515200A5 publication Critical patent/JP2005515200A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003548835A 2001-11-30 2002-12-02 睡眠異常症（ｓｌｅｅｐｄｉｓｏｒｄｅｒ）等の治療、目覚め時の爽快感の付与を目的とした一化合物の使用及び前記化合物を用いた足元のふらつき（ｇｒｏｇｇｉｎｅｓｓ）の治療法 Pending JP2005515200A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0128674.9A GB0128674D0 (en) 2001-11-30 2001-11-30 Treatment of sleep disorders and the like
US10/305,354 US20030134878A1 (en) 2001-11-30 2002-11-27 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
PCT/GB2002/005427 WO2003047580A1 (en) 2001-11-30 2002-12-02 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith

Publications (2)

Publication Number Publication Date
JP2005515200A true JP2005515200A (ja) 2005-05-26
JP2005515200A5 JP2005515200A5 (zh) 2006-01-05

Family

ID=9926729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003548835A Pending JP2005515200A (ja) 2001-11-30 2002-12-02 睡眠異常症（ｓｌｅｅｐｄｉｓｏｒｄｅｒ）等の治療、目覚め時の爽快感の付与を目的とした一化合物の使用及び前記化合物を用いた足元のふらつき（ｇｒｏｇｇｉｎｅｓｓ）の治療法

Country Status (13)

Country Link
US (4) US20030134878A1 (zh)
EP (1) EP1455786A1 (zh)
JP (1) JP2005515200A (zh)
CN (1) CN1617723A (zh)
AU (2) AU2002313364B2 (zh)
CA (1) CA2468044A1 (zh)
GB (3) GB0128674D0 (zh)
IL (1) IL162146A0 (zh)
NO (1) NO20042389L (zh)
PL (1) PL370258A1 (zh)
RU (1) RU2320340C2 (zh)
WO (1) WO2003047580A1 (zh)
ZA (1) ZA200404172B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312425D0 (en) * 2003-05-30 2003-07-09 Boots Co Plc Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
US20060270658A1 (en) * 2003-09-03 2006-11-30 Donald Manning Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
KR100870381B1 (ko) 2004-10-14 2008-11-25 다이킨 고교 가부시키가이샤 분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
US20070299127A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
CN101868253A (zh) * 2007-11-21 2010-10-20 宝洁公司 可用于咳嗽治疗的制剂、方法和试剂盒
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
IL254641B2 (en) 2015-03-26 2024-01-01 Jacqueline M Iversen Methods and preparations including naproxen and fexofenamide for relieving symptoms of dizziness associated with alcohol consumption

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US4639459A (en) * 1983-02-01 1987-01-27 Burroughs Wellcome Co. Use of trifluoromethyl compounds
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
PT1202722E (pt) * 1999-08-13 2005-11-30 L & L Technologies Llc Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina
IL157634A0 (en) * 2001-03-13 2004-03-28 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms containing glucocorticosteroid
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Also Published As

Publication number Publication date
US20030134878A1 (en) 2003-07-17
ZA200404172B (en) 2005-09-01
CN1617723A (zh) 2005-05-18
US20040029927A1 (en) 2004-02-12
IL162146A0 (en) 2005-11-20
AU2002350897A1 (en) 2003-06-17
AU2002350897B2 (en) 2008-12-11
GB0227708D0 (en) 2003-01-08
PL370258A1 (en) 2005-05-16
RU2320340C2 (ru) 2008-03-27
WO2003047580A1 (en) 2003-06-12
US20070015800A1 (en) 2007-01-18
GB0128674D0 (en) 2002-01-23
CA2468044A1 (en) 2003-06-12
GB2383537B (en) 2003-12-10
RU2004119832A (ru) 2005-04-20
NO20042389L (no) 2004-06-08
EP1455786A1 (en) 2004-09-15
GB2383537A (en) 2003-07-02
GB0228045D0 (en) 2003-01-08
US20050282869A1 (en) 2005-12-22
AU2002313364B2 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
RU2354374C2 (ru) Применение соединения для лечения нарушений сна
US20070015800A1 (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
EP3209298B1 (en) Compositions for treating insomnia
US11890272B2 (en) Non-sedating dexmedetomidine treatment regimens
MXPA06014605A (es) Composicion farmaceutica orodispersable para la administracion oromucosal o sublingual de agomelatina.
WO2022147537A1 (en) Dexmedetomidine treatment regimens
US20030008005A1 (en) Sublingual administration of dihydroergotamine for the treatment of migraine
JP2005515200A5 (zh)
CN117715641A (zh) 用神经活性类固醇进行治疗的方法
RU2372915C2 (ru) Применение трипролидина в обеспечении бодрости при пробуждении
JP5148801B2 (ja) 催眠用固形製剤
US11998529B2 (en) Non-sedating dexmedetomidine treatment regimens
Patel Comparison of bronchodilator effect of tulobuterol and salbutamol aerosols in patients with asthma.
RU2483733C2 (ru) Лечение нарушений сна
Friths et al. Temazepam versus nitrazepam: A comparative trial in the treatment of sleep disturbances

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050725

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050725

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090327

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090629

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090706

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091120